GHP Investment Advisors’s AstraZeneca AZN Stock Holding History

GHP Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.5K	Sell	166 -634	-79%	-$119K	﹤0.01%	637
2026 Q1	$158K	Buy	800 +650	+433%	+$125K	0.01%	415
2025 Q4	$27.6K	Hold	150	–	–	﹤0.01%	601
2025 Q3	$23K	Hold	150	–	–	﹤0.01%	615
2025 Q2	$21K	Hold	150	–	–	﹤0.01%	621
2025 Q1	$22.1K	Hold	150	–	–	﹤0.01%	590
2024 Q4	$19.7K	Sell	150 -75	-33%	-$10.5K	﹤0.01%	606
2024 Q3	$35K	Buy	225 +60	+36%	+$9.69K	﹤0.01%	550
2024 Q2	$25.7K	Buy	+165	New	+$24.8K	﹤0.01%	565
2023 Q1	–	Sell	-59	Closed	-$7.93K	–	923
2022 Q4	$7.93K	Hold	59	–	–	﹤0.01%	728
2022 Q3	$6K	Buy	+59	New	+$7.49K	﹤0.01%	760

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GHP Investment Advisors's AZN Position: Q2 2026 in Review

GHP Investment Advisors reduced its AstraZeneca (AZN) stake by 79% in Q2 2026, selling an estimated $119K and leaving 166 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

GHP Investment Advisors first reported a position in AZN in Q3 2022 and has held it in 11 quarters since. The position peaked at $158K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

GHP Investment Advisors held 166 shares of AstraZeneca worth $31.5K as of Q2 2026.
GHP Investment Advisors sold 634 AstraZeneca shares in Q2 2026, an estimated $119K.
AstraZeneca made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #637 holding.
GHP Investment Advisors first reported a position in AstraZeneca in Q3 2022 and has held it in 11 quarters since.
GHP Investment Advisors's AstraZeneca position peaked at $158K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.